| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 07/14/2005 | CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/14/2005 | CA2546981A1 Optically active, heteroaromatic .beta.-hydroxy esters, processes for their preparation from .beta.-keto esters and processes for the preparation of these .beta.-keto esters |
| 07/13/2005 | EP1551834A1 Substituted quinazolinone compounds |
| 07/13/2005 | CN1639150A 异喹啉衍生物 Isoquinoline derivatives |
| 07/13/2005 | CN1639127A Process for asymmetric hydrogenation of hexahydroquinoline salts |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916905 Dmt-Tic di-and tri-peptidic derivatives and related compositions and methods of use |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916837 Such as 2-(6-amidino-2-naphthyloxy)-5-methanesulfonyl-aminobenzoic acid trifluoroacetate; blood coaggulation factor VII inhibitors |
| 07/12/2005 | US6916830 Substituted tetrahydroisoquinolines as C5a receptor modulators |
| 07/07/2005 | WO2005061460A1 Compounds, compositions, and methods |
| 07/07/2005 | WO2005061459A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | WO2005060456A2 Method for treating adamts-5-associate disease |
| 07/07/2005 | US20050148776 Process for asymmetric hydrogenation of hexahydroquinoline salts |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/07/2005 | US20050148625 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
| 07/07/2005 | US20050148624 Enzyme inhibitors with isoquinolinone structures |
| 07/07/2005 | US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/07/2005 | US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/06/2005 | EP1549685A1 Novel nitrosation polymer in organic synthesis |
| 07/06/2005 | EP1485357B1 Process for asymmetric hydrogenation of hexahydroquinoline salts |
| 07/06/2005 | CN1634892A Method for resolution of isoquinolines |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | US20050143415 For the production of a pharmaceutical agent for therapy of inflammatory diseases |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1432686B1 Tetrahydroisochinolines, their production and the use thereof as analgesics |
| 06/29/2005 | CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/28/2005 | US6911456 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists |
| 06/28/2005 | US6911453 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/23/2005 | WO2005056013A1 Dpp-iv inhibitors |
| 06/23/2005 | WO2002068380A8 Synthetic excitatory amino acids |
| 06/23/2005 | US20050137200 Potassium channel modulators; antiarrhythmia agents |
| 06/22/2005 | EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 06/22/2005 | EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1268466B1 Decahydro-isoquinolines |
| 06/22/2005 | CN1630642A Benzenesulfonamide derivatives |
| 06/22/2005 | CN1630640A Novel enantiomer of tetra hydrogen isoquinoline derivative and officinal salt, preparation and pharmaceutical composition thereof |
| 06/22/2005 | CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use |
| 06/21/2005 | US6908931 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders |
| 06/21/2005 | US6908911 Antibacterial agents |
| 06/16/2005 | WO2005054202A1 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b) |
| 06/16/2005 | WO2005054176A1 Peroxisome proliferator activated receptor modulators |
| 06/16/2005 | WO2005053610A2 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 06/16/2005 | WO2005040150A3 Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors |
| 06/16/2005 | US20050131231 Process for preparing cyclic N-substituted alpha-imino carboxlic acids |
| 06/16/2005 | US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |
| 06/16/2005 | US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/16/2005 | CA2547356A1 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 06/16/2005 | CA2547212A1 Peroxisome proliferator activated receptor modulators |
| 06/15/2005 | EP1541559A1 5-substituted isoquinoline derivative |
| 06/15/2005 | EP1541148A1 Dpp-iv inhibitors |
| 06/15/2005 | EP1539701A1 Caspase inhibitors and uses thereof |
| 06/15/2005 | EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 06/15/2005 | EP1539687A1 Substituted glycine derivatives for use as medicaments |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1373240B1 Retinoid x receptor modulators |
| 06/15/2005 | CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 06/15/2005 | CN1626540A Iridium compound and organic electroluminescent device using the same |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/09/2005 | WO2005051945A1 Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treatment and/or prevention of disorders modulated by a ppar |
| 06/09/2005 | WO2005051391A1 Quinazolinone compounds with reduced bioaccumulation |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124652 Guanidino compounds |
| 06/09/2005 | US20050124614 E. g., 3,5-bis-trifluoromethylphenyl)-4-[(furan-2-ylmethyl)-aminocarbonyl]-2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline;anticarcinogenic agents; antitumor agents; antiproliferative agents; activators of the caspase cascades; enzyme inhibitors used in combination with radiation or chemotherapy |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | DE10351904A1 Verfahren zur Herstellung von cyclischen N-substituierten alpha-Iminocarbonsäure A process for the preparation of cyclic N-substituted alpha-iminocarboxylic acid |
| 06/09/2005 | CA2545601A1 Quinazolinone compounds with reduced bioaccumulation |
| 06/08/2005 | EP1538160A1 Substituted Isoquinolin-3-carboxyamides, their preparation and medical use |
| 06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/07/2005 | US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903114 Carbocyclic alcohols such as 1,6-dinitronaphthalene-2,3-diol, used as catechol-O-methyltransferase inhibitors, for prophylaxis of Parkinson's disease |
| 06/07/2005 | US6903107 Serine protease inhibitor |
| 06/07/2005 | US6903094 As analgesic |
| 06/02/2005 | WO2005049577A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 |
| 06/02/2005 | WO2005049576A1 Substitute isoquinolines useful in the treatment of diseases such as cancer and atherosclerosis |
| 06/02/2005 | WO2005049023A1 Glyt1 transporter inhibitors |
| 06/02/2005 | WO2005048810A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 06/02/2005 | US20050119495 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119227 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |